RG

Redmile Group Portfolio holdings

AUM $940M
1-Year Est. Return 75.78%
This Quarter Est. Return
1 Year Est. Return
+75.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$377M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1 +$20.2M
2 +$5.95M
3 +$5.19M
4
PODD icon
Insulet
PODD
+$4.61M
5
MASI icon
Masimo
MASI
+$4.34M

Top Sells

1 +$12M
2 +$12M
3 +$11M
4
ISRG icon
Intuitive Surgical
ISRG
+$8.84M
5
ARDX icon
Ardelyx
ARDX
+$7.99M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRK icon
1
Scholar Rock
SRRK
$2.83B
$141M 13.37%
4,398,281
-151,600
KRYS icon
2
Krystal Biotech
KRYS
$5.45B
$133M 12.57%
737,675
-15,500
FOLD icon
3
Amicus Therapeutics
FOLD
$2.5B
$77.8M 7.35%
9,533,669
+2,478,779
ZYME icon
4
Zymeworks
ZYME
$1.4B
$57M 5.39%
4,788,945
-51,518
NRIX icon
5
Nurix Therapeutics
NRIX
$771M
$48.1M 4.55%
4,051,927
-140,700
REPL icon
6
Replimune Group
REPL
$365M
$47.8M 4.51%
4,898,527
-7,000
LIVN icon
7
LivaNova
LIVN
$2.94B
$39.8M 3.77%
1,014,139
-29,400
AKRO icon
8
Akero Therapeutics
AKRO
$4.3B
$38M 3.59%
939,277
-295,932
IMNM icon
9
Immunome
IMNM
$1.44B
$36.1M 3.41%
5,361,187
+533,161
RGNX icon
10
Regenxbio
RGNX
$623M
$34.3M 3.24%
4,794,780
BEAM icon
11
Beam Therapeutics
BEAM
$2.61B
$31.4M 2.97%
1,610,329
+81,762
STOK icon
12
Stoke Therapeutics
STOK
$1.87B
$29.8M 2.82%
4,485,981
-107,648
KYMR icon
13
Kymera Therapeutics
KYMR
$4.32B
$26.9M 2.54%
983,413
-117,019
ADCT icon
14
ADC Therapeutics
ADCT
$465M
$22.1M 2.09%
15,666,731
BHVN icon
15
Biohaven
BHVN
$1.74B
$20.9M 1.97%
867,454
-37,042
ABSI icon
16
Absci
ABSI
$728M
$20.7M 1.96%
8,253,316
BSX icon
17
Boston Scientific
BSX
$145B
$19.5M 1.84%
193,283
-119,400
COGT icon
18
Cogent Biosciences
COGT
$2.29B
$19.3M 1.82%
3,216,026
-338,810
NGNE icon
19
Neurogene
NGNE
$485M
$15.3M 1.45%
1,308,063
-11,700
ETNB icon
20
89bio
ETNB
$2.19B
$13.7M 1.3%
1,886,444
-280,732
ESTA icon
21
Establishment Labs
ESTA
$1.35B
$13.7M 1.29%
335,366
+15,217
ANNX icon
22
Annexon
ANNX
$348M
$12.2M 1.15%
6,300,644
CLDX icon
23
Celldex Therapeutics
CLDX
$1.76B
$10.7M 1.01%
590,175
-25,600
FATE icon
24
Fate Therapeutics
FATE
$178M
$10.2M 0.96%
12,872,946
IDYA icon
25
IDEAYA Biosciences
IDYA
$2.43B
$8.76M 0.83%
534,600
-84,700